Given that both in vitro and in vivo paradigms of ADAM10 inhibition have successfully restored the density of long-lasting spines in HD hippocampal neurons, we sought to determine whether interfering with ADAM10 activity could induce NMDAR-dependent LTP. The gene discussed is ADAM10; the disease is Huntington disease.